Office of Public Sector Information
PART 7 continued CHAPTER 6 continued
(1) If the FHSAA removes the practitioner from a list, it may also decide to disqualify him from inclusion in—
(a) the pharmaceutical lists prepared by each Primary Care Trust,
(b) the supplementary lists prepared by each Primary Care Trust,
(c) the lists under section 91, 106, or 123 prepared by each Primary Care Trust,
(d) the lists under section 146 prepared by each Primary Care Trust, or the lists corresponding to the lists under section 91 prepared by each Primary Care Trust by virtue of regulations made under section 145,
(e) the lists corresponding to the lists mentioned in paragraphs (a) to (d) prepared by each Local Health Board under or by virtue of the National Health Service (Wales) Act 2006 (c. 42),
or only from inclusion in one or more descriptions of such lists prepared by each Primary Care Trust and each Local Health Board, the description being specified by the FHSAA in its decision.
(2) A decision by the FHSAA to do what is mentioned in subsection (1) is referred to in this section as the imposition of a national disqualification.
(3) The FHSAA may also impose a national disqualification on a practitioner if it dismisses an appeal by him against the refusal by a Primary Care Trust to include him in such a list.
(4) The Primary Care Trust may apply to the FHSAA for a national disqualification to be imposed on a person after the Primary Care Trust has—
(a) removed him from a list prepared by it of any of the kinds referred to in subsection (1)(a) to (d), or
(b) refused to include him in such a list.
(5) Any such application must be made before the end of the period of three months beginning with the date of the removal or of the Primary Care Trust’s refusal.
(6) If the FHSAA imposes a national disqualification on a person—
(a) no Primary Care Trust or Local Health Board may include him in a list of any of the kinds prepared by it from which he has been disqualified from inclusion, and
(b) if he is included in such a list, each Primary Care Trust and each Local Health Board in whose list he is included must remove him from it.
(7) The FHSAA may at the request of the person upon whom it has been imposed review a national disqualification, and on a review may confirm it or revoke it.
(8) Subject to subsection (9), the person may not request such a review before the end of the period of—
(a) two years beginning with the date on which the national disqualification was imposed, or
(b) one year beginning with the date of the FHSAA’s decision on the last such review.
(9) The Secretary of State may provide in regulations for subsection (8) to have effect in prescribed circumstances as if the reference there to “two years” or “one year” were a reference to a different period specified in the regulations.
Regulations may require a Primary Care Trust to notify prescribed persons, or persons of prescribed descriptions, of any decision it makes under this Chapter, and of any information relevant to the decision which it considers appropriate to include in the notification.
Regulations may provide for circumstances in which a practitioner—
(a) whom a Primary Care Trust is investigating in order to see whether there are grounds for exercising its powers under section 151, 152 or 154,
(b) whom a Primary Care Trust has decided to remove from a list under section 151 or 152, or contingently remove under section 152, but who has not yet been removed or contingently removed, or
(c) who has been suspended under section 154,
may not withdraw from a list in which he is included.
(1) Any decision by a Primary Care Trust referred to in this Chapter must be reached in accordance with regulations about such decisions.
(2) The regulations must include provision—
(a) requiring the practitioner to be given notice of any allegation against him,
(b) giving him the opportunity of putting his case at a hearing before a Primary Care Trust makes any decision affecting him under this Chapter,
(c) requiring him to be given notice of the decision of the Primary Care Trust and the reasons for it and of any right of appeal which he may have.
(3) The regulations may, in particular, make provision as to criteria which the Primary Care Trust must apply when making decisions in unsuitability cases.
(1) This section applies where it appears to the Secretary of State that there is provision in Scotland or Northern Ireland under which a person may be dealt with in any way which corresponds (whether or not exactly) with a way in which a person may be dealt with under this Chapter.
(2) A decision in Scotland or Northern Ireland to deal with such a person in such a way is referred to in this section as a “corresponding decision”.
(3) If this section applies, the Secretary of State may make regulations providing for the effect to be given in England to a corresponding decision.
(4) That effect need not be the same as the effect of the decision in the place where it was made.
(5) The regulations may not provide for a corresponding decision to be reviewed or revoked in England.
(1) The remuneration to be paid to persons who provide pharmaceutical services under this Part must be determined by determining authorities.
(2) Determining authorities may also determine the remuneration to be paid to persons who provide those services in respect of the instruction of any person in matters relating to those services.
(3) For the purposes of this section and section 165 determining authorities are—
(a) the Secretary of State, and
(b) so far as authorised by him to exercise the functions of determining authorities, any Primary Care Trust or other person appointed by him in an instrument.
(4) The instrument mentioned in subsection (3)(b) is called in this section an “instrument of appointment”.
(5) An instrument of appointment—
(a) may contain requirements with which a determining authority appointed by that instrument must comply in making determinations, and
(b) may be contained in regulations.
(6) Subject to this section and section 165, regulations may make provision about determining remuneration under this section and may in particular impose requirements with which determining authorities must comply in making, or in connection with, determinations (including requirements as to consultation and publication).
(7) Regulations may provide that determinations may be made by reference to any of—
(a) rates or conditions of remuneration of any persons or any descriptions of persons which are fixed or determined, or will be fixed or determined, otherwise than by way of a determination under this section,
(b) scales, indices or other data of any description specified in the regulations.
(8) Where regulations provide as mentioned in subsection (7)(b), they may provide that any determination which falls to be made by reference to a scale, index or other data may be made by reference to the scale, index or data—
(a) in the form current at the time of the determination, and
(b) in any subsequent form taking effect after that time.
(9) Regulations may—
(a) provide that determining authorities may make determinations which have effect in relation to remuneration in respect of a period beginning on or after a date specified in the determination, which may be the date of the determination or an earlier or later date, but may be an earlier date only if, taking the determination as a whole, it is not detrimental to the persons to whose remuneration it relates,
(b) provide that any determination which does not specify such a date has effect in relation to remuneration in respect of a period beginning—
(i) if it is required to be published, on the date of publication,
(ii) if it is not so required, on the date on which it is made.
(10) A reference in this section or section 165 to a determination is to a determination of remuneration under this section.
(1) Before a determination is made by the Secretary of State which relates to all persons who provide pharmaceutical services, or a category of such services, he—
(a) must consult a body appearing to him to be representative of persons to whose remuneration the determination would relate, and
(b) may consult such other persons as he considers appropriate.
(2) Determinations may make different provision for different cases, including different provision for any particular case, class of case or area.
(3) Determinations may be—
(a) made in more than one stage,
(b) made by more than one determining authority,
(c) varied or revoked by subsequent determinations.
(4) A determination may be varied—
(a) to correct an error, or
(b) where it appears to the determining authority that it was made in ignorance of or under a mistake as to a relevant fact.
(5) Determinations may, in particular, provide that the whole or any part of the remuneration—
(a) is payable only if the determining authority is satisfied as to certain conditions, or
(b) must be applied for certain purposes or is otherwise subject to certain conditions.
(6) Remuneration under section 164 may be determined from time to time and may consist of payments by way of—
(a) salary,
(b) fees,
(c) allowances,
(d) reimbursement (in full or in part) of expenses incurred or expected to be incurred in connection with the provision of the services or instruction.
(7) At the time a determination is made or varied, certain matters which require determining may be reserved to be decided at a later time.
(8) The matters which may be reserved include in particular—
(a) the amount of remuneration to be paid in particular cases,
(b) whether any remuneration is to be paid in particular cases.
(9) Any determination may be made only after taking into account all the matters which are considered to be relevant by the determining authority.
(10) Such matters may include in particular—
(a) the amount or estimated amount of expenses (taking into account any discounts) incurred in the past or likely to be incurred in the future (whether or not by persons to whose remuneration the determination will relate) in connection with the provision of pharmaceutical services or of any category of pharmaceutical services,
(b) the amount or estimated amount of any remuneration paid or likely to be paid to persons providing such services,
(c) the amount or estimated amount of any other payments or repayments or other benefits received or likely to be received by any such persons,
(d) the extent to which it is desirable to encourage the provision, either generally or in particular places, of pharmaceutical services or the category of pharmaceutical services to which the determination will relate,
(e) the desirability of promoting pharmaceutical services which are—
(i) economic and efficient, and
(ii) of an appropriate standard.
(11) If the determination is of remuneration for a category of pharmaceutical services, the reference in subsection (10)(a) to a category of pharmaceutical services is a reference to the same category of pharmaceutical services or to any other category of pharmaceutical services falling within the same description.
(1) Regulations may make provision for the purpose of securing that, in prescribed circumstances, prescribed persons included in a pharmaceutical list hold approved indemnity cover.
(2) The regulations may, in particular, make provision as to the consequences of a failure to hold approved indemnity cover, including provision—
(a) for securing that a person must not be added to a pharmaceutical list unless he holds approved indemnity cover,
(b) for the removal from a pharmaceutical list prepared by a Primary Care Trust of a person who does not within a prescribed period after the making of a request by the Primary Care Trust in the prescribed manner satisfy the Primary Care Trust that he holds approved indemnity cover.
(3) For the purposes of this section—
“approved body” means a person or persons approved in relation to indemnity cover of any description, after such consultation as may be prescribed, by the Secretary of State or by such other person as may be prescribed,
“approved indemnity cover” means indemnity cover made—
on prescribed terms, and
with an approved body,
“indemnity cover”, in relation to a person included in a pharmaceutical list (or a person who proposes to provide pharmaceutical services), means a contract of insurance or other arrangement made for the purpose of indemnifying him, and any person prescribed in relation to him, to any prescribed extent against any liability which—
arises out of the provision of pharmaceutical services in accordance with arrangements made by him with a Primary Care Trust, and
is incurred by him or any such person in respect of the death or personal injury of a person,
“personal injury” means any disease or impairment of a person’s physical or mental condition and includes the prolongation of any disease or such impairment,
and a person holds approved indemnity cover if he has entered into a contract or arrangement which constitutes approved indemnity cover.
(4) The regulations may provide that a person of any description who has entered into a contract or arrangement which is—
(a) in a form identified in accordance with the regulations in relation to persons of that description, and
(b) made with a person or persons so identified,
must be treated as holding approved indemnity cover for the purposes of the regulations.
(1) A Primary Care Trust may recognise a committee formed for its area, or for its area and that of one or more other Primary Care Trusts, which it is satisfied is representative of—
(a) the persons providing pharmaceutical services from premises in the area for which the committee is formed (“pharmaceutical services providers”),
(b) pharmaceutical services providers and the persons to whom subsections (2) and (3) apply,
(c) pharmaceutical services providers and the persons to whom subsection (2) applies, or
(d) pharmaceutical services providers and the persons to whom subsection (3) applies.
(2) This subsection applies to each person who—
(a) is providing local pharmaceutical services in the Primary Care Trust’s area under an LPS scheme made (whether with himself or another person) by the Primary Care Trust, and
(b) has notified the Primary Care Trust that he wishes to be represented by the committee (and has not notified it that he wishes to cease to be so represented).
(3) This subsection applies to each person who—
(a) is providing local pharmaceutical services in the Primary Care Trust’s area under a pilot scheme made (whether with himself or another person) by the Primary Care Trust, and
(b) has notified the Primary Care Trust that he wishes to be represented by the committee (and has not notified it that he wishes to cease to be so represented).
(4) A committee recognised under this section is called the Local Pharmaceutical Committee for the area for which it is formed.
(5) Any such committee may delegate any of its functions, with or without restrictions or conditions, to sub-committees composed of members of that committee.
(6) Regulations may require a Primary Care Trust, in the exercise of functions relating to pharmaceutical services or local pharmaceutical services, to consult committees recognised by it under this section on such occasions and to such extent as may be prescribed.
(7) Subsection (6) does not affect any other power to require a Primary Care Trust to consult committees recognised by it under this section.
(8) A committee recognised under this section has such other functions as may be prescribed.
(9) A Primary Care Trust may, on the request of any committee recognised by it under this section, allot to that committee such sums for defraying the committee’s administrative expenses (other than any determined under subsection (12)) as may be determined by the Primary Care Trust.
(10) Any sums so allotted must be out of the moneys available to the Primary Care Trust for the remuneration of persons of whom the committee is representative under subsection (1)(a).
(11) The amount of any such sums must be deducted from the remuneration of those persons in such manner as may be determined by the Primary Care Trust.
(12) A committee recognised under subsection (1)(b), (c) or (d) must, in respect of each year, determine the amount of its administrative expenses for that year attributable to the persons of whom it is representative under subsection (2) or (3).
(13) The committee must apportion the amount determined under subsection (12) among the persons of whom it is representative under subsection (2) or (3), and each such person must pay in accordance with the committee’s directions the amount so apportioned to him.
(14) The administrative expenses of a committee include the travelling and subsistence allowances payable to its members.
If the Secretary of State considers that any accommodation provided by him by virtue of this Act is suitable for use in connection with the provision of pharmaceutical services or local pharmaceutical services, he may make the accommodation available on such terms as he considers appropriate to persons providing those services.
National Health Service Act 2006